.Nature Medicine, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint requires incorporation of clients along with MASLD and size of liver outcomes in cardio-- renal-- metabolic tests, when data propose mechanistically probable perks and professional protection-- as well as lays out factors for trial design and also regulative commendation.